查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1462937

同种异体干细胞移植市场，按细胞类型、来源、应用、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Allogeneic Stem Cell Transplantation Market, By Cell Type, By Source, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 299 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023年异体干细胞移植市场规模为38.3334亿美元，2024年至2032年复合CAGR为7.8%。

异体干细胞移植市场-市场动态

血液系统恶性肿瘤和非恶性疾病盛行率上升推动市场需求

由于血液系统恶性肿瘤和非恶性疾病盛行率上升，同种异体干细胞移植市场预计将大幅成长，这种移植方法已显示出前景。此外，研发投资的增加以及干细胞疗法的强大管道预计将推动市场扩张。探索各个治疗领域的同种异体干细胞移植的临床试验数量不断增加，这预示着未来市场的成长。癌症、自体免疫疾病和血液疾病等慢性疾病发生率的增加是同种异体干细胞移植市场的关键驱动力。过去十年来，白血病、多发性骨髓瘤和淋巴瘤等疾病的病例都稳定上升。同种异体造血干细胞移植为许多这些高风险和抗药性血液恶性肿瘤提供了潜在的治疗方法。据世界卫生组织 (WHO) 称，2020 年，癌症在全球造成近 1000 万人死亡。目前正在进行大量研究和临床试验，以评估同种异体干细胞疗法在传统血癌和疾病之外的新应用的安全性和有效性。多项第 2 期和第 3 期试验正在研究同种异体干细胞疗法治疗骨髓纤维化、骨关节炎、中风、创伤性脑损伤和心肌炎等疾病。旨在扩大治疗领域的稳健管道活动将为市场成长开闢新途径。例如，全球製药公司诺华公司已启动一项利用同种异体干细胞移植治疗骨髓纤维化的2期临床试验，预计完成日期为2024年10月。

同种异体干细胞移植市场-关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 7.8% 左右的CAGR成长

根据来源细分，预计骨髓将在 2023 年显示最大的市场份额

根据最终用户细分，医院是 2023 年的领先类型

按地区划分，北美是 2023 年的主要收入来源

同种异体干细胞移植市场-細項分析：

全球同种异体干细胞移植市场根据细胞类型、来源、应用、最终用户和地区进行细分。

市场依来源分为两类：骨髓、週边血、脐带血、脂肪组织、牙髓等。骨髓同种异体干细胞移植市场预计在 2023 年占据重要的全球市场份额。 。对于符合条件的个人来说，这种治疗方式至关重要，因为它有可能显着延长预期寿命，并且通常不会復发。

根据最终用户，市场分为三类：医院、研究所、专科诊所和其他。到 2023 年，医院最终用户部分将主要贡献于同种异体干细胞移植服务，这主要是由于现代医院内拥有先进的医疗基础设施。值得注意的是，当代医院配备了尖端的医疗技术，包括专门从事骨髓移植的专业单位。这些资源使医院能够为造血干细胞移植 (HSCT) 接受者提供全面的移植前和移植后护理，特别是在美国、德国、英国、中国和印度等地区。

同种异体干细胞移植市场-地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲地区。这些区域根据开展业务的国家进一步划分。

同种异体干细胞移植市场-竞争格局：

公司和医疗机构正在实施策略措施，以改善患者的治疗效果、促进创新并增加获得移植服务的机会。该策略的一个重要方面涉及透过专门的研究和开发努力不断进步移植技术和方案。这包括对移植物抗宿主疾病（GVHD）创新预防方法的投资、预处理方案的完善以及探索替代干细胞来源以扩大资格标准并提高移植成功率。与学术机构和研究组织的合作在验证和优化这些进步、确保其临床适用性和有效性方面发挥着至关重要的作用。

最近的发展：

2023年9月，法国生技公司MaaT Pharma宣布，欧洲药品管理局（EMA）已授予MaaT033孤儿药资格。 MaaT033 由 MaaT Pharma 开发，是一种辅助和维持疗法，旨在提高同种异体造血干细胞移植（allo-HSCT）的整体存活率。

目录

第一章：同种异体干细胞移植市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按细胞类型分類的同种异体干细胞移植市场片段
    • 同种异体干细胞移植市场片段（依来源）
    • 同种异体干细胞移植市场片段（依应用）
    • 最终用户的同种异体干细胞移植市场片段
    • 按国家/地区分類的同种异体干细胞移植市场片段
    • 按地区分類的同种异体干细胞移植市场片段
  • 竞争洞察

第 3 章：同种异体干细胞移植主要市场趋势

  • 同种异体干细胞移植市场驱动因素
    • 市场驱动因素的影响分析
  • 同种异体干细胞移植市场限制
    • 市场限制影响分析
  • 同种异体干细胞移植市场机会
  • 异体干细胞移植市场未来趋势

第四章：同种异体干细胞移植产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：同种异体干细胞移植市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：同种异体干细胞移植市场格局

  • 2023 年同种异体干细胞移植市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：同种异体干细胞移植市场 - 依细胞类型

  • 概述
    • 按电池类型分類的细分市场份额分析
    • 同种异体间质干细胞
    • 同种异体造血干细胞
    • 其他的

第 8 章：同种异体干细胞移植市场 - 按来源

  • 概述
    • 按来源分類的细分市场占有率分析
    • 骨髓
    • 週边血
    • 脐带血
    • 脂肪组织
    • 牙髓
    • 其他的

第 9 章：同种异体干细胞移植市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 癌症
    • 自体免疫疾病
    • 血液疾病
    • 心臟疾病
    • 神经系统疾病
    • 糖尿病
    • 其他的

第 10 章：同种异体干细胞移植市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 医院
    • 研究机构
    • 专科诊所
    • 其他的

第 11 章：同种异体干细胞移植市场 - 依地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美同种异体干细胞移植主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按电池类型）
    • 北美市场规模与预测（按来源）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲同种异体干细胞移植主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按电池类型）
    • 欧洲市场规模与预测（按来源）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区同种异体干细胞移植主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模和预测（按电池类型）
    • 亚太地区市场规模与预测（按来源）
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲同种异体干细胞移植主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模和预测（按电池类型）
    • 拉丁美洲市场规模与预测（按来源）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲同种异体干细胞移植主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按电池类型）
    • 中东和非洲市场规模及预测（按来源）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第12章：主要供应商分析-同种异体干细胞移植产业

  • 竞争仪表板
  • 公司简介
    • Celgene Corporation
    • Mesoblast Ltd.
    • Pluristem Therapeutics Inc.
    • MEDIPOST Co., Ltd.
    • Osiris Therapeutics, Inc.
    • Cynata Therapeutics Limited
    • Takeda Pharmaceutical Company Limited
    • Astellas Pharma Inc.
    • Cellular Biomedicine Group, Inc.
    • Biosolution Co., Ltd.
    • StemCell Technologies Inc.
    • Caladrius Biosciences, Inc.
    • ViaCord
    • Vericel Corporation
    • Regen Biopharma Inc.
    • Gamida Cell Ltd.
    • Histogenics Corporation
    • BrainStorm Cell Therapeutics Inc.
    • Lineage Cell Therapeutics, Inc.
    • Others

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2395

REPORT HIGHLIGHT

Allogeneic Stem Cell Transplantation Market size was valued at USD 3,833.34 Million in 2023, expanding at a CAGR of 7.8% from 2024 to 2032.

Allogeneic stem cell transplantation involves the transfer of healthy stem cells from a genetically compatible donor to the patient, replacing damaged cells. This established therapeutic technique is used to address various hematological cancers, blood disorders, and immunological conditions. Stem cells for allogeneic transplants can be sourced from peripheral blood, bone marrow, umbilical cord blood, or adipose tissue. The field has witnessed significant progress in harvesting methods, expansion protocols, cryopreservation, and cell processing.

Allogeneic Stem Cell Transplantation Market- Market Dynamics

Rising prevalence of hematologic malignancies and non-malignant disorders to propel market demand

The Allogeneic Stem Cell Transplantation Market is expected to witness substantial growth driven by the rising prevalence of hematologic malignancies and non-malignant disorders, where this transplantation method has shown promise. Additionally, increased investments in research and development, along with a robust pipeline of stem cell therapies, are anticipated to propel market expansion. The rising number of clinical trials exploring allogeneic stem cell transplantation across various therapeutic areas bodes well for future market growth. The increasing incidence of chronic diseases like cancer, autoimmune disorders, and blood ailments is a key driver for the allogeneic stem cell transplantation market. Cases of diseases such as leukemia, multiple myeloma, and lymphoma have steadily risen over the past decade. Allogeneic hematopoietic stem cell transplantation offers a potentially curative approach for many of these high-risk and drug-resistant hematological malignancies. According to the World Health Organization (WHO), cancer caused nearly 10 million deaths worldwide in 2020. The growing pool of patients and demand for advanced therapies to address these conditions will fuel market growth. Numerous research studies and clinical trials are underway to assess the safety and efficacy of allogeneic stem cell therapies for new applications beyond traditional blood cancers and disorders. Several phase 2 and 3 trials are investigating allogeneic stem cell therapies for conditions such as bone marrow fibrosis, osteoarthritis, stroke, traumatic brain injury, and myocarditis, among others. Robust pipeline activities aimed at expanding the treatment landscape will open up new avenues for market growth. For example, Novartis, a global pharmaceutical company, has initiated a phase 2 clinical trial using allogeneic stem cell transplantation to treat bone marrow fibrosis, with an expected completion date of October 2024.

Allogeneic Stem Cell Transplantation Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.8% over the forecast period (2024-2032)

Based on Source segmentation, Bone Marrow was predicted to show maximum market share in the year 2023

Based on End User segmentation, Hospitals was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Allogeneic Stem Cell Transplantation Market- Segmentation Analysis:

The Global Allogeneic Stem Cell Transplantation Market is segmented on the basis of Cell Type, Source, Application, End User, and Region.

The market is divided into two categories based on Source: Bone Marrow, Peripheral Blood, Umbilical Cord Blood, Adipose Tissue, Dental Pulp, and Others. The bone marrow allogeneic stem cell transplantation market is poised to command a significant global market share in 2023. Bone marrow stem cell transplantation emerges as a promising therapeutic avenue for select hematological disorders, particularly in cases where conventional treatments have proven ineffective or disease recurrence has transpired. For eligible individuals, this treatment modality holds paramount importance as it offers the potential to extend life expectancy significantly, often free from relapse.

The market is divided into three categories based on End User: Hospitals, Research Institutes, Specialty Clinics, and Others. In 2023, the hospital end user segment predominantly contributes to allogeneic stem cell transplantation services, primarily owing to the sophisticated medical infrastructure available within modern hospitals. Notably, contemporary hospitals are equipped with cutting-edge medical technologies, including specialized units dedicated to bone marrow transplantation. These resources empower hospitals to deliver comprehensive pre- and post-transplant care to hematopoietic stem cell transplant (HSCT) recipients, particularly in regions such as the United States, Germany, the United Kingdom, China, and India.

Allogeneic Stem Cell Transplantation Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Allogeneic Stem Cell Transplantation Market- Competitive Landscape:

Companies and healthcare institutions are implementing strategic measures to enhance patient outcomes, foster innovation, and enhance access to transplantation services. A crucial aspect of this strategy involves continual advancements in transplant technologies and protocols through dedicated research and development endeavors. This encompasses investments in innovative prophylaxis methods for graft-versus-host disease (GVHD), refinement of conditioning regimens, and exploration of alternative stem cell sources to broaden eligibility criteria and enhance transplant success rates. Collaborations with academic institutions and research organizations play a vital role in validating and optimizing these advancements, ensuring their clinical applicability and effectiveness.

Recent Developments:

In September 2023, MaaT Pharma, a biotechnology company based in France, announced that the European Medicines Agency (EMA) has granted orphan drug designation to MaaT033. Developed by MaaT Pharma, MaaT033 is an adjunctive and maintenance therapy aimed at improving overall survival in Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT).

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ALLOGENEIC STEM CELL TRANSPLANTATION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHT

Celgene Corporation

Mesoblast Ltd.

Pluristem Therapeutics Inc.

MEDIPOST Co., Ltd.

Osiris Therapeutics, Inc.

Cynata Therapeutics Limited

Takeda Pharmaceutical Company Limited

Astellas Pharma Inc.

Cellular Biomedicine Group, Inc.

Biosolution Co., Ltd.

StemCell Technologies Inc.

Caladrius Biosciences, Inc.

ViaCord

Vericel Corporation

Regen Biopharma Inc.

Gamida Cell Ltd.

Histogenics Corporation

BrainStorm Cell Therapeutics Inc.

Lineage Cell Therapeutics, Inc.

Others

GLOBAL ALLOGENEIC STEM CELL TRANSPLANTATION MARKET, BY CELL TYPE - MARKET ANALYSIS, 2019 - 2032

  • Allogeneic MSCs
  • Allogeneic HSCs
  • Others

GLOBAL ALLOGENEIC STEM CELL TRANSPLANTATION MARKET, BY SOURCE- MARKET ANALYSIS, 2019 - 2032

  • Bone Marrow
  • Peripheral Blood
  • Umbilical Cord Blood
  • Adipose Tissue
  • Dental Pulp
  • Others

GLOBAL ALLOGENEIC STEM CELL TRANSPLANTATION MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Cancer
  • Autoimmune Diseases
  • Blood Disorders
  • Cardiac Disorders
  • Neurological Disorders
  • Diabetes
  • Others

GLOBAL ALLOGENEIC STEM CELL TRANSPLANTATION MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Research Institutes
  • Specialty Clinics
  • Others

GLOBAL ALLOGENEIC STEM CELL TRANSPLANTATION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Allogeneic Stem Cell Transplantation Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Allogeneic Stem Cell Transplantation Market Snippet by Cell Type
    • 2.1.2.Allogeneic Stem Cell Transplantation Market Snippet by Source
    • 2.1.3.Allogeneic Stem Cell Transplantation Market Snippet by Application
    • 2.1.4.Allogeneic Stem Cell Transplantation Market Snippet by End User
    • 2.1.5.Allogeneic Stem Cell Transplantation Market Snippet by Country
    • 2.1.6.Allogeneic Stem Cell Transplantation Market Snippet by Region
  • 2.2.Competitive Insights

3.Allogeneic Stem Cell Transplantation Key Market Trends

  • 3.1.Allogeneic Stem Cell Transplantation Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Allogeneic Stem Cell Transplantation Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Allogeneic Stem Cell Transplantation Market Opportunities
  • 3.4.Allogeneic Stem Cell Transplantation Market Future Trends

4.Allogeneic Stem Cell Transplantation Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Allogeneic Stem Cell Transplantation Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Allogeneic Stem Cell Transplantation Market Landscape

  • 6.1.Allogeneic Stem Cell Transplantation Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Allogeneic Stem Cell Transplantation Market - By Cell Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Cell Type, 2023 & 2032 (%)
    • 7.1.2.Allogeneic MSCs
    • 7.1.3.Allogeneic HSCs
    • 7.1.4.Others

8.Allogeneic Stem Cell Transplantation Market - By Source

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Source, 2023 & 2032 (%)
    • 8.1.2.Bone Marrow
    • 8.1.3.Peripheral Blood
    • 8.1.4.Umbilical Cord Blood
    • 8.1.5.Adipose Tissue
    • 8.1.6.Dental Pulp
    • 8.1.7.Others

9.Allogeneic Stem Cell Transplantation Market - By Application

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2.Cancer
    • 9.1.3.Autoimmune Diseases
    • 9.1.4.Blood Disorders
    • 9.1.5.Cardiac Disorders
    • 9.1.6.Neurological Disorders
    • 9.1.7.Diabetes
    • 9.1.8.Others

10.Allogeneic Stem Cell Transplantation Market - By End User

  • 10.1.Overview
    • 10.1.1.Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 10.1.2.Hospitals
    • 10.1.3.Research Institutes
    • 10.1.4.Specialty Clinics
    • 10.1.5.Others

11.Allogeneic Stem Cell Transplantation Market- By Geography

  • 11.1.Introduction
    • 11.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2.North America
    • 11.2.1.Overview
    • 11.2.2.Allogeneic Stem Cell Transplantation Key Manufacturers in North America
    • 11.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4.North America Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.2.5.North America Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.2.6.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7.North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.8.U.S.
      • 11.2.8.1.Overview
      • 11.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3.U.S. Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4.U.S. Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.2.8.5.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6.U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.9.Canada
      • 11.2.9.1.Overview
      • 11.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3.Canada Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4.Canada Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.2.9.5.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6.Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3.Europe
    • 11.3.1.Overview
    • 11.3.2.Allogeneic Stem Cell Transplantation Key Manufacturers in Europe
    • 11.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4.Europe Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.3.5.Europe Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.3.6.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7.Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.8.Germany
      • 11.3.8.1.Overview
      • 11.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3.Germany Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4.Germany Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.8.5.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6.Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.9.Italy
      • 11.3.9.1.Overview
      • 11.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3.Italy Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4.Italy Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.9.5.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6.Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.10.United Kingdom
      • 11.3.10.1.Overview
      • 11.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3.United Kingdom Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4.United Kingdom Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.10.5.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6.United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.11.France
      • 11.3.11.1.Overview
      • 11.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3.France Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4.France Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.11.5.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6.France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.12.Russia
      • 11.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2.Russia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3.Russia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.12.4.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.5.Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.13.Netherlands
      • 11.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2.Netherlands Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3.Netherlands Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.13.4.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.5.Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.14.Sweden
      • 11.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2.Sweden Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3.Sweden Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.14.4.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.5.Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.15.Poland
      • 11.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2.Poland Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3.Poland Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.15.4.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.5.Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.16.Rest of Europe
      • 11.3.16.1.Overview
      • 11.3.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3.Rest of the Europe Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4.Rest of the Europe Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.16.5.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6.Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4.Asia Pacific (APAC)
    • 11.4.1.Overview
    • 11.4.2.Allogeneic Stem Cell Transplantation Key Manufacturers in Asia Pacific
    • 11.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4.Asia Pacific Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.4.5.Asia Pacific Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.4.6.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7.Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.8.India
      • 11.4.8.1.Overview
      • 11.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3.India Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4.India Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.8.5.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6.India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.9.China
      • 11.4.9.1.Overview
      • 11.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3.China Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4.China Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.9.5.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6.China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.10.Japan
      • 11.4.10.1.Overview
      • 11.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3.Japan Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4.Japan Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.10.5.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6.Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.11.South Korea
      • 11.4.11.1.Overview
      • 11.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3.South Korea Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4.South Korea Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.11.5.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6.South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.12.Australia
      • 11.4.12.1.Overview
      • 11.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3.Australia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4.Australia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.12.5.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6.Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.13.Thailand
      • 11.4.13.1.Overview
      • 11.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3.Thailand Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4.Thailand Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.13.5.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6.Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.14.Indonesia
      • 11.4.14.1.Overview
      • 11.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3.Indonesia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4.Indonesia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.14.5.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6.Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.15.Philippines
      • 11.4.15.1.Overview
      • 11.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3.Philippines Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4.Philippines Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.15.5.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6.Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.16.Rest of APAC
      • 11.4.16.1.Overview
      • 11.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3.Rest of APAC Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4.Rest of APAC Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.16.5.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6.Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5.Latin America
    • 11.5.1.Overview
    • 11.5.2.Allogeneic Stem Cell Transplantation Key Manufacturers in Latin America
    • 11.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4.Latin America Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.5.5.Latin America Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.5.6.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7.Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.8.Brazil
      • 11.5.8.1.Overview
      • 11.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3.Brazil Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4.Brazil Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.8.5.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6.Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.9.Mexico
      • 11.5.9.1.Overview
      • 11.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3.Mexico Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4.Mexico Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.9.5.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6.Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.10.Argentina
      • 11.5.10.1.Overview
      • 11.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3.Argentina Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4.Argentina Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.10.5.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6.Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.11.Colombia
      • 11.5.11.1.Overview
      • 11.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3.Colombia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4.Colombia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.11.5.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6.Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.12.Rest of LATAM
      • 11.5.12.1.Overview
      • 11.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3.Rest of LATAM Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4.Rest of LATAM Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.12.5.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6.Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6.Middle East and Africa
    • 11.6.1.Overview
    • 11.6.2.Allogeneic Stem Cell Transplantation Key Manufacturers in Middle East and Africa
    • 11.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4.Middle East and Africa Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.6.5.Middle East and Africa Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.6.6.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7.Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.8.Saudi Arabia
      • 11.6.8.1.Overview
      • 11.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3.Saudi Arabia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4.Saudi Arabia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.8.5.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6.Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.9.United Arab Emirates
      • 11.6.9.1.Overview
      • 11.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3.United Arab Emirates Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4.United Arab Emirates Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.9.5.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6.United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.10.Israel
      • 11.6.10.1.Overview
      • 11.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3.Israel Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4.Israel Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.10.5.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6.Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.11.Turkey
      • 11.6.11.1.Overview
      • 11.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3.Turkey Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4.Turkey Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.11.5.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6.Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.12.Algeria
      • 11.6.12.1.Overview
      • 11.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3.Algeria Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4.Algeria Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.12.5.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6.Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.13.Egypt
      • 11.6.13.1.Overview
      • 11.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3.Egypt Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4.Egypt Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.13.5.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6.Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.14.Rest of MEA
      • 11.6.14.1.Overview
      • 11.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3.Rest of MEA Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4.Rest of MEA Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.14.5.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6.Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12.Key Vendor Analysis- Allogeneic Stem Cell Transplantation Industry

  • 12.1.Competitive Dashboard
  • 12.2.Company Profiles
    • 12.2.1.Celgene Corporation
    • 12.2.2.Mesoblast Ltd.
    • 12.2.3.Pluristem Therapeutics Inc.
    • 12.2.4.MEDIPOST Co., Ltd.
    • 12.2.5.Osiris Therapeutics, Inc.
    • 12.2.6.Cynata Therapeutics Limited
    • 12.2.7.Takeda Pharmaceutical Company Limited
    • 12.2.8.Astellas Pharma Inc.
    • 12.2.9.Cellular Biomedicine Group, Inc.
    • 12.2.10.Biosolution Co., Ltd.
    • 12.2.11.StemCell Technologies Inc.
    • 12.2.12.Caladrius Biosciences, Inc.
    • 12.2.13.ViaCord
    • 12.2.14.Vericel Corporation
    • 12.2.15.Regen Biopharma Inc.
    • 12.2.16.Gamida Cell Ltd.
    • 12.2.17.Histogenics Corporation
    • 12.2.18.BrainStorm Cell Therapeutics Inc.
    • 12.2.19.Lineage Cell Therapeutics, Inc.
    • 12.2.20.Others

13.360 Degree Analyst View

14.Appendix

  • 14.1.Research Methodology
  • 14.2.References
  • 14.3.Abbreviations
  • 14.4.Disclaimer
  • 14.5.Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Allogeneic Stem Cell Transplantation Market: Cell Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Cell Type
  • TABLE Global Allogeneic Stem Cell Transplantation Market, by Cell Type 2019-2032 (USD Million)
  • TABLE Allogeneic Stem Cell Transplantation Market: Source Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Source
  • TABLE Global Allogeneic Stem Cell Transplantation Market, by Source 2019-2032 (USD Million)
  • TABLE Allogeneic Stem Cell Transplantation Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Allogeneic Stem Cell Transplantation Market, by Application 2019-2032 (USD Million)
  • TABLE Allogeneic Stem Cell Transplantation Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Allogeneic Stem Cell Transplantation Market, by End User 2019-2032 (USD Million)
  • TABLE Allogeneic Stem Cell Transplantation Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Allogeneic Stem Cell Transplantation Market, by Region 2019-2032 (USD Million)
  • TABLE North America Allogeneic Stem Cell Transplantation Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Allogeneic Stem Cell Transplantation Market, by Cell Type, 2019-2032 (USD Million)
  • TABLE North America Allogeneic Stem Cell Transplantation Market, by Source, 2019-2032 (USD Million)
  • TABLE North America Allogeneic Stem Cell Transplantation Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Allogeneic Stem Cell Transplantation Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Allogeneic Stem Cell Transplantation Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Allogeneic Stem Cell Transplantation Market, by Cell Type, 2019-2032 (USD Million)
  • TABLE Europe Allogeneic Stem Cell Transplantation Market, by Source, 2019-2032 (USD Million)
  • TABLE Europe Allogeneic Stem Cell Transplantation Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Allogeneic Stem Cell Transplantation Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Allogeneic Stem Cell Transplantation Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Allogeneic Stem Cell Transplantation Market, by Cell Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Allogeneic Stem Cell Transplantation Market, by Source, 2019-2032 (USD Million)
  • TABLE Asia Pacific Allogeneic Stem Cell Transplantation Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Allogeneic Stem Cell Transplantation Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Allogeneic Stem Cell Transplantation Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Allogeneic Stem Cell Transplantation Market, by Cell Type, 2019-2032 (USD Million)
  • TABLE Latin America Allogeneic Stem Cell Transplantation Market, by Source, 2019-2032 (USD Million)
  • TABLE Latin America Allogeneic Stem Cell Transplantation Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Allogeneic Stem Cell Transplantation Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Allogeneic Stem Cell Transplantation Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Allogeneic Stem Cell Transplantation Market, by Cell Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Allogeneic Stem Cell Transplantation Market, by Source, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Allogeneic Stem Cell Transplantation Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Allogeneic Stem Cell Transplantation Market, by End User, 2019-2032 (USD Million)

List of Figures

  • FIGURE Allogeneic Stem Cell Transplantation Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Cell Type segment market share analysis, 2023 & 2032
  • FIGURE Cell Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Source segment market share analysis, 2023 & 2032
  • FIGURE Source segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Application segment market share analysis, 2023 & 2032
  • FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE End User segment market share analysis, 2023 & 2032
  • FIGURE End User segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Allogeneic Stem Cell Transplantation Market share and leading players, 2023
  • FIGURE Europe Allogeneic Stem Cell Transplantation Market share and leading players, 2023
  • FIGURE Asia Pacific Allogeneic Stem Cell Transplantation Market share and leading players, 2023
  • FIGURE Latin America Allogeneic Stem Cell Transplantation Market share and leading players, 2023
  • FIGURE Middle East and Africa Allogeneic Stem Cell Transplantation Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Allogeneic Stem Cell Transplantation Market share analysis by country, 2023
  • FIGURE Germany Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Allogeneic Stem Cell Transplantation Market share analysis by country, 2023
  • FIGURE India Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Phillipines Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Allogeneic Stem Cell Transplantation Market share analysis by country, 2023
  • FIGURE Brazil Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Allogeneic Stem Cell Transplantation Market share analysis by country, 2023
  • FIGURE Saudi Arabia Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Allogeneic Stem Cell Transplantation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)